Influence of p53 Pathway in Determining Efficacy or Toxicity of Treatment with Novel Polo-Like Kinase-1 (PLK1) Targeted Anti-Cancer Therapeutic Agents (ITTP PhD Studentship)

StatusFinished
Effective start/end date1/10/1330/09/17

Funding

  • Medical Research Council: £83,712.00